FDA.reportPublic FDA data

Bladder tumour-associated mutation IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used to evaluate a clinical specimen to diagnose, monitor or predict one or multiple acquired mutations associated with bladder cancer e.g., aneuploidies of chromosome 3, 7 and 17, in a clinical specimen.
GUDID devices
1
Last updated
2019-04-02 01:31:57

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00884999002128UroVysionABBOTT MOLECULAR INC.02J27-0112014-11-20